BPOM Oversees Biosimilar Development and Export Expansion in Sidoarjo
Jakarta (ANTARA) - The Indonesian Food and Drug Authority (BPOM) has stated that it is overseeing the progress of biosimilar technology development and the expansion of processed food exports in Sidoarjo through monitoring and evaluation activities.
BPOM Head Taruna Ikrar stated in Jakarta on Thursday that his visits to PT Bernofarm and PT Sekar Laut Tbk demonstrate the agency’s commitment to performing its multi-layered protection function for the public, while simultaneously acting as an enabler to support national pharmaceutical independence and food security in the global market.
“BPOM has officially issued the Good Manufacturing Practice (GMP) Certificate for the drug substance and drug product facilities for PT Bernofarm’s biosimilar clinical trial products,” he said.
In issuing the GMP Certificate, BPOM applies a strict supervision system from pre-market to post-market stages to guarantee product safety. Taruna emphasised that this rigorous oversight is an absolute responsibility of the regulator in protecting the community.
“Our task is to ensure that all standard procedures are strictly followed. This supervision is not intended to make things difficult, but to protect. If errors occur in the future, hundreds of billions in investment could be lost, and the public would be the victims. That is why we are serious about this oversight,” he said.
“Thank you, Prof. Taruna, for your support from last year until now and for being willing to personally review the progress of our facilities. We are also very grateful that last month we received the GMP certificate for biosimilar products for clinical trial scale. This is a major step forward for us as we move to the next stage,” said Haryanto.
Furthermore, BPOM inspected the processed food factory of PT Sekar Laut Tbk, a cracker producer with a production capacity of 25 tonnes per day, which has obtained nine certificates for the Implementation of Good Processed Food Production Practices (IP CPPOB).
Taruna explained that this food industry has been exporting to more than 30 countries and has received approval from the Saudi Food and Drug Authority (SFDA) since August 2025.
The agency directly inspected all production lines to ensure there were no gaps for physical or dangerous chemical contamination. This monitoring step is mandatory to maintain public health and to fortify the sustainability of local industries.
“Our background is clear: ensuring safety and quality in protecting the public from pre-market to post-market. Export certificates are not merely stamps; they are guarantees. Monitoring and evaluation are mandatory for us. This is so that we not only protect the public but also protect the industry,” explained Taruna Ikrar regarding his visit.
“BPOM is a strategic partner for us, especially two years ago when we were processing approval numbers for Saudi Arabia. Thanks to BPOM’s assistance, the permit was issued promptly. Alhamdulillah, the system is now online-based, and BPOM’s service shows very good progress,” said Bambang.
Through this series of monitoring and evaluation visits, BPOM has proven that strict international-standard supervision can synergise public health protection with the strengthening of the national economy.
“BPOM’s presence at these drug and food production facilities ensures that products made by the nation’s children are safe for domestic consumption and possess high competitiveness on the international stage,” he concluded.
Source: jawawa.id (https://jawawa.id/newsitem/bpom-oversees-biosimilar-development-and-export-expansion-in-sidoarjo-1781787408)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5613429/bpom-kawal-progres-biosimilar-ekspansi-ekspor-industri-sidoarjo), translated from Indonesian